Nirsevimab immunization’s real-world effectiveness in preventing severe bronchiolitis: A test-negative case-control study
Pediatr Allergy Immunol. 2024 Jun;35(6):e14175. doi: 10.1111/pai.14175. ABSTRACT BACKGROUND: Several clinical trials have shown that nirsevimab, an antibody targeting the respiratory syncytial virus (RSV), reduces …